198 related articles for article (PubMed ID: 22168313)
1. Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China.
Wang H; Liu J; Dilimulati ; Li L; Ren Z; Wen H; Wang X
Virol J; 2011 Dec; 8():539. PubMed ID: 22168313
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Kaposi's sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China.
Zheng J; Yang Y; Cui M; Shu ZJ; Han LL; Liu ZQ; Wood C; Zhang T; Zeng Y
Virol Sin; 2017 Oct; 32(5):396-403. PubMed ID: 29116591
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.
Fu B; Sun F; Li B; Yang L; Zeng Y; Sun X; Xu F; Rayner S; Guadalupe M; Gao SJ; Wang L
J Med Virol; 2009 Aug; 81(8):1422-31. PubMed ID: 19551832
[TBL] [Abstract][Full Text] [Related]
4. Social behavioral correlates of Kaposi sarcoma-associated herpesvirus infection among Han and Uygur populations in Xinjiang, China.
Yuan H; Liu Z; Wu X; Fang Q; Zheng J; Zeng Y; Zhang T
J Med Virol; 2019 Mar; 91(3):457-462. PubMed ID: 30281827
[TBL] [Abstract][Full Text] [Related]
5. Genotypic analysis of Kaposi's sarcoma-associated herpesvirus from patients with Kaposi's sarcoma in Xinjiang, China.
Ouyang X; Zeng Y; Fu B; Wang X; Chen W; Fang Y; Luo M; Wang L
Viruses; 2014 Nov; 6(12):4800-10. PubMed ID: 25431948
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.
Liu Z; Fang Q; Zhou S; Minhas V; Wood C; He N; Zhang T
J Med Virol; 2017 Sep; 89(9):1629-1635. PubMed ID: 28252177
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Jiuquan area, China.
Fang Y; Li W; Zhang Y; Zhou C; Wu H; Zhang Y; Dai T; Wang J; Wang L; Chen T; Zhu Y; Wang L
J Med Virol; 2022 Dec; 94(12):6016-6022. PubMed ID: 35922376
[TBL] [Abstract][Full Text] [Related]
8. Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China.
Dilnur P; Katano H; Wang ZH; Osakabe Y; Kudo M; Sata T; Ebihara Y
Pathol Int; 2001 Nov; 51(11):845-52. PubMed ID: 11844050
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York City.
Engels EA; Clark E; Aledort LM; Goedert JJ; Whitby D
Int J Epidemiol; 2002 Oct; 31(5):946-50. PubMed ID: 12435765
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China.
Cao Y; Minhas V; Tan X; Huang J; Wang B; Zhu M; Gao Y; Zhao T; Yang L; Wood C
Clin Microbiol Infect; 2014 May; 20(5):475-81. PubMed ID: 23992104
[TBL] [Abstract][Full Text] [Related]
11. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.
Olsen SJ; Chang Y; Moore PS; Biggar RJ; Melbye M
AIDS; 1998 Oct; 12(14):1921-5. PubMed ID: 9792393
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus seropositivity is associated with type 2 diabetes mellitus: A case-control study in Xinjiang, China.
Cui M; Fang Q; Zheng J; Shu Z; Chen Y; Fan Y; Zhao J; Wood C; Zhang T; Zeng Y
Int J Infect Dis; 2019 Mar; 80():73-79. PubMed ID: 30639407
[TBL] [Abstract][Full Text] [Related]
13. Virological and molecular characterization of Kaposi's sarcoma-associated herpesvirus strains from Xinjiang, China.
Wang X; Wang H; He B; Hui Y; Lv G; Li L; Wen H
Eur J Clin Microbiol Infect Dis; 2012 Jan; 31(1):53-9. PubMed ID: 21537910
[TBL] [Abstract][Full Text] [Related]
14. Environmental risk factors and genetic markers of Kaposi's sarcoma-associated herpesvirus infection among Uygur population in Xinjiang, China.
Zhang X; Fang Q; Zhu S; Wu X; Yuan H; Liu Z; Xu Y; Chen T; Zeng Y; Zhang T
J Med Virol; 2022 Jun; 94(6):2755-2765. PubMed ID: 35043408
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Kaposi's sarcoma associated herpesvirus among men attending sexually transmitted infections clinics in Anhui, China.
Wang J; Liu S; Cao Y; Yang L; Chen Y; Minhas V; Wood C; Zhang T
J Med Virol; 2016 Feb; 88(2):304-11. PubMed ID: 26147809
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV).
Chatlynne LG; Ablashi DV
Semin Cancer Biol; 1999 Jun; 9(3):175-85. PubMed ID: 10343069
[TBL] [Abstract][Full Text] [Related]
18. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
Lin SF; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
J Virol; 1997 Apr; 71(4):3069-76. PubMed ID: 9060668
[TBL] [Abstract][Full Text] [Related]
19. EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.
Blumenthal MJ; Schutz C; Meintjes G; Mohamed Z; Mendelson M; Ambler JM; Whitby D; Mackelprang RD; Carse S; Katz AA; Schäfer G
Cancer Epidemiol; 2018 Oct; 56():133-139. PubMed ID: 30176543
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.
He F; Wang X; He B; Feng Z; Lu X; Zhang Y; Zhao S; Lin R; Hui Y; Bao Y; Zhang Z; Wen H
J Med Virol; 2007 Feb; 79(2):161-6. PubMed ID: 17177299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
